Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry W Moreland

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Pharmacoeconomics|May 26, 2004
Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritisLarry W Moreland
The New England Journal of Medicine|December 13, 2005
Febuxostat--treatment for hyperuricemia and gout?Larry W Moreland
The Journal of Rheumatology. Supplement|July 6, 2007
Disease modifiers: making the right therapeutic choices for our patientsLarry W Moreland
Arthritis Research & Therapy|April 30, 2003
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of actionLarry W Moreland
Arthritis and Rheumatism|November 6, 2012
Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et alLarry W Moreland
Annals of the New York Academy of Sciences|January 16, 2010
Cytokines as targets for anti-inflammatory agentsLarry W Moreland
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Biologic therapies on the horizon for rheumatoid arthritisLarry W Moreland
Current Opinion in Pharmacology|May 19, 2024
Editorial overview: Special issue on "Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases"Larry W Moreland, Kristine Kuhn
Expert Opinion on Investigational Drugs|June 27, 2002
Rheumatoid arthritis: developing pharmacological therapiesRichard J Misischia, Larry W Moreland
Current Rheumatology Reports|September 24, 2009
Methotrexate versus combination methotrexate and etanercept for rheumatoid arthritisAarat M Patel, Larry W Moreland
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Pharmacoeconomics|May 26, 2004
Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritisLarry W Moreland
The New England Journal of Medicine|December 13, 2005
Febuxostat--treatment for hyperuricemia and gout?Larry W Moreland
The Journal of Rheumatology. Supplement|July 6, 2007
Disease modifiers: making the right therapeutic choices for our patientsLarry W Moreland
Arthritis Research & Therapy|April 30, 2003
Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of actionLarry W Moreland
Arthritis and Rheumatism|November 6, 2012
Reply: The effect of triple therapy versus etanercept plus methotrexate in rheumatoid arthritis: comment on the article by Moreland et alLarry W Moreland
Annals of the New York Academy of Sciences|January 16, 2010
Cytokines as targets for anti-inflammatory agentsLarry W Moreland
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 18, 2006
Biologic therapies on the horizon for rheumatoid arthritisLarry W Moreland
Current Opinion in Pharmacology|May 19, 2024
Editorial overview: Special issue on "Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases"Larry W Moreland, Kristine Kuhn
Expert Opinion on Investigational Drugs|June 27, 2002
Rheumatoid arthritis: developing pharmacological therapiesRichard J Misischia, Larry W Moreland
Current Rheumatology Reports|September 24, 2009
Methotrexate versus combination methotrexate and etanercept for rheumatoid arthritisAarat M Patel, Larry W Moreland
Pageof 18